News
STAT | New study raises questions about early-stage cancer therapies for children
Published: 21 February 2018
At this early stage, the potential for harm is real while the benefits are only surrogate measures, said Kimmelman, an associate professor of biomedical ethics at ÎÛÎÛ²ÝÝ®ÊÓƵ University. One such measure at Phase 1 might be tumor shrinkage, which does not necessarily translate into what people really care about: survival.